Publications
Selected publications from my research on neuroimaging biomarkers in ALS.
J. Neurology
2026
2026
#### [Data-driven disease subgrouping in ALS: a multicenter cerebral functional connectivity study](https://doi.org/10.1007/s00415-026-13624-4)
*Journal of Neurology* · 2026 · Co-Author
Dey A, Baumeister TR, Evans KC, Koppelmans V, Luk C, McLaren DG, **Parnianpour P**, Seres P, Kalra S, Canadian ALS Neuroimaging Consortium.
This multicenter study used functional connectivity data from CALSNIC to identify distinct ALS patient subgroups based on cerebral functional connectivity patterns, advancing our understanding of disease heterogeneity and supporting precision medicine approaches in ALS.
Ann. Neurology
2025
2025
#### An individual-level MRI approach reveals corticospinal tract degeneration and its heterogeneity in ALS
*Annals of Neurology* · 2025 · Co-Author · *(submitted)*
Harrison M, Liu G, **Parnianpour P**, Dey A, Baumeister TR, Abrahao A, Dupre N, Genge A, Zinman L, CALSNIC, CAPTURE ALS, Kalra S.
Using an individual-level analysis of MRI data, this study reveals heterogeneity in corticospinal tract degeneration across ALS patients -- an important step toward personalized imaging-based stratification in clinical trials.
AJNR
2025
2025
#### [Progressive and short-interval changes observed in the corticospinal tract and corpus callosum of ALS patients: A texture analysis study](https://doi.org/10.3174/ajnr.A9013)
*American Journal of Neuroradiology* · 2025 · **First Author**
**Parnianpour P**, Harrison M, Benatar M, Briemberg H, Dionne A, Dupre N, Frayne R, Genge A, Graham SJ, Korngut L, Seres P, Wilman A, Zinman L, Kalra S, Canadian ALS Neuroimaging Consortium.
Using standard T1-weighted MRI, we applied sectional texture analysis to track ALS-related changes over 4--8 months. We observed progressive degeneration starting asymmetrically in the right corticospinal tract, with corpus callosum changes emerging later -- correlated with upper motor neuron dysfunction.
Brain Comms
2024
2024
#### [T1-weighted MRI texture analyses in ALS patients stratified by the D50 progression model](https://doi.org/10.1093/braincomms/fcae389)
*Brain Communications* · 2024 · **First Author**
**Parnianpour P**, Steinbach R, Buchholz IJ, Grosskreutz J, Kalra S.
This study explores texture analysis on T1-weighted 1.5T MRI scans, stratifying ALS patients by disease severity using the D50 disease progression model. Our findings demonstrate that texture analysis can differentiate ALS progression stages, offering a promising biomarker applicable across MRI scanner strengths.
J. Neurology
2024
2024
#### [Mismatch between clinically defined classification of ALS stage and the burden of cerebral pathology](https://doi.org/10.1007/s00415-024-12190-x)
*Journal of Neurology* · 2024 · **First Author**
**Parnianpour P**, Benatar M, Briemberg H, Dey A, Dionne A, Dupre N, Evans KC, Frayne R, Genge A, Graham SJ, Korngut L, McLaren DG, Seres P, Welsh RC, Wilman A, Zinman L, Kalra S.
The traditional clinical staging of ALS does not accurately reflect the level of neurodegeneration. This study demonstrates the mismatch between clinical stage and cerebral pathology burden, arguing that imaging should be incorporated into disease stratification in clinical trials.
Sci. Reports
2023
2023
#### [Accurate personalized survival prediction for amyotrophic lateral sclerosis patients](https://doi.org/10.1038/s41598-023-47935-7)
*Scientific Reports* · 2023 · Co-Author
Kuan LH, **Parnianpour P**, Kushol R, Kumar N, Anand T, Kalra S, Greiner R.
A machine-learned tool that accurately predicts ALS patient survival time by integrating clinical features with cortical thickness data from brain MRI. Predictions are expressed as individual survival distributions (ISDs), giving probabilistic estimates at multiple future time points.
Sci. Reports
2023
2023
#### [Effects of MRI scanner manufacturers in classification tasks with deep learning models](https://doi.org/10.1038/s41598-023-43715-5)
*Scientific Reports* · 2023 · Co-Author
Kushol R, **Parnianpour P**, Wilman AH, Kalra S, Yang YH.
This study investigates domain shift in deep learning for multi-center MRI data across scanner manufacturers (GE, Philips, Siemens), evaluating harmonization strategies for robust classification in clinical neuroimaging pipelines.
PhD Thesis
MRI-Based Texture Analysis for Characterizing Cerebral Degeneration Progression in Amyotrophic Lateral Sclerosis
University of Alberta, 2024 · Supervisor: Dr. Sanjay Kalra
This thesis leverages MRI-based texture analysis to delineate cerebral degeneration progression in ALS: assessing gray and white matter changes by disease stage, detecting longitudinal cerebral changes, analyzing degeneration within specific neural tracts, and classifying ALS patients based on cerebral degeneration patterns.
Conference Abstracts
Podium Presentations
- “Enhancing ALS Clinical Trial Efficiency Using Longitudinal Measures of Brain Function” – ALS EnCouRAge Canada, Toronto, Canada, April 2026
- “Trial-ready power estimates for longitudinal resting-state fMRI biomarkers in ALS” (Invited) – The 4th International Computational Neuroimaging Society Meeting, Trinity College Dublin, Nov 2025
- “Resting-state fMRI as a translational biomarker for ALS therapeutics” – The 2025 Annual NEALS Meeting, Clearwater, FL, Oct 2025
- “T1-weighted MRI texture analysis in ALS patients stratified by the D50 disease progression model” – The 13th Neuroimaging Society in ALS (NiSALS) Meeting, Montreal, Canada, Dec 2024
- “Along-tract texture analysis of MRI in the corticospinal tract and corpus callosum in ALS” – The 34th International Symposium on ALS/MND, Basel, Switzerland, Dec 2023
- “Sectional texture analysis of white matter tracts in ALS” – ALS Canada Research Forum, Toronto, Canada, June 2023
- “Texture analysis to capture ALS pathology in different levels of upper motor neuron involvement” – OHBM Annual Meeting, Glasgow, UK, 2022
- “Texture analysis reveals cerebral degeneration in ALS: a multicenter study” – OHBM Annual Meeting, Virtual, 2021
- “Texture analysis detects cerebral degeneration in ALS” – ALS Canada Research Forum, Toronto, Canada, 2021
Poster Presentations
- “Trial-Ready Power Estimates for Longitudinal Resting-state fMRI Biomarkers in ALS” (Poster #906) – ISMRM Annual Meeting, Cape Town, South Africa, May 2026 (presented by Dr. Erik P. Pioro)
- ALS Canada Research Forum, June 2023
- OHBM Annual Meeting, 2021
- ALS Canada Research Forum, June 2021
- OHBM Annual Meeting, June 2019
- ALS Canada Research Forum, April 2019
- Alberta Imaging Symposium (AIS), May 2019
- The 7th International Conference on Cognitive Science (ICCS), 2017 (two presentations)